Docetaxel (Taxotere) as monotherapy in the treatment of hormone-refractory prostate cancer: Preliminary results

被引：0
|
作者：
Picus, J
Schultz, M
机构：
[1] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[2] John Cochran Vet Adm Hosp, St Louis, MO USA
来源：
SEMINARS IN ONCOLOGY | 1999年 / 26卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：14 / 18
页数：5
相关论文
共 50 条
  • [1] Docetaxel (Taxotere) in hormone-refractory prostate cancer
    Petrylak, DP
    [J]. SEMINARS IN ONCOLOGY, 2000, 27 (02) : 24 - 29
  • [2] Preliminary evaluation of a short course of estramustine phosphate and docetaxel (Taxotere) in the treatment of hormone-refractory prostate cancer
    Sinibaldi, VJW
    Carducci, M
    Laufer, M
    Eisenberger, M
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (05) : 45 - 48
  • [3] Docetaxel (Taxotere)-based chemotherapy for hormone-refractory and locally advanced prostate cancer
    Oh, WK
    Kantoff, PW
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (05) : 49 - 54
  • [4] Docetaxel (Taxotere) in hormone-refractory prostate cancer: A new addition to the physicians' toolbag
    Vogelzang, NJ
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (05) : 1 - 2
  • [5] Daily oral estramustine and intermittent intravenous docetaxel (Taxotere) as chemotherapeutic treatment for metastatic, hormone-refractory prostate cancer
    Kreis, W
    Budman, D
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (05) : 34 - 38
  • [6] Docetaxel and exisulind in hormone-refractory prostate cancer
    Ryan, CW
    Stadler, WM
    Vogelzang, NJ
    [J]. SEMINARS IN ONCOLOGY, 2001, 28 (04) : 56 - 61
  • [7] Docetaxel in hormone-refractory metastatic prostate cancer
    Oh, WK
    [J]. DRUGS, 2005, 65 (16) : 2296 - 2297
  • [8] Docetaxel for hormone-refractory prostate cancer Reply
    Damber, Jan-Erik
    Aus, Gunnar
    [J]. LANCET, 2008, 372 (9648): : 1461 - 1462
  • [9] Phase I/II studies of docetaxel (Taxotere) combined with estramustine in men with hormone-refractory prostate cancer
    Petrylak, DP
    Macarthur, R
    O'Connor, J
    Shelton, G
    Weitzman, A
    Judge, T
    England-Owen, C
    Zuech, N
    Pfaff, C
    Newhouse, J
    Bagiella, E
    Hetjan, D
    Sawczuk, I
    Benson, M
    Olsson, C
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (05) : 28 - 33
  • [10] Weekly docetaxel and epirubicin in treatment of advanced hormone-refractory prostate cancer
    Petrioli, Roberto
    Paolelli, Loretta
    Francini, Edoardo
    Manganelli, Antonio
    Salvestrini, Francesco
    Francini, Guido
    [J]. UROLOGY, 2007, 69 (01) : 142 - 146
12345